1KostikasK, PapatheodorouG, GanasK, et al. PH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med,2002,165 : 1364 - 1370.
2Richard M, Richard Casaburi, Jennifer Su, et al. The Effects of Volatile Salivary Acids and Bases on Exhaled Breath Condensate PH. Am J Respir Crit Care Med ,2006,15 ; 173 (4) :386 - 392.
3HUNT F, KEZHONG FANG, RAJESH MALIK, et al. Endogenous Airway Acidification:Implications for Asthma PathoPHysiology. Am J Respir Crit Care Med,2000,161 (3 Pt 1 ) :694- 699.
4John Hunt, Yuanlin Yu, James Burns, et al. Identification of acid reflux cough using serial assays of exhaled breath condensate PH. Cough, 2006 Apr,11;2:3.
5Torrego A, Cimbollek S, Hew M, No effect of omeprazole on PH of exhaled breath condensate in cough associated with gastro-oeso PH ageal reflux. Cough ,2005 Oct, 19 ; 1 : 10.
6Ojoo JC, Mulrennan SA, Kastelik JA, et al. Exhaled breath condensate PH and exhaled nitric oxide in Allergic asthma and in cystic fibrosis. Thorax,2005 Jan,60 ( 1 ) :22 -6.
7Walsh BK, Mackey DJ, Pajewski T, et al. Exhaled-Breath Condensate PH Can Be Safely and Continuously Monitored in Mechanically Ventilated Patients. Respir Care,2006,51 ( 10 ) : 1125 - 1131.
8Carpagnano GE, Spanevello A, Sabato R, et al. Exhaled PH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. Transl Res,2008 Jan, 151 ( 1 ) :45 - 50.
9Petrosyan M, Perraki E, Simoes D, et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath ,2007,11.
10Luigia Brunetti, Ruggiero Francavilla, Riccardina Tesse, et al. Exhaled breath condensate PH measurement in children with asthma, allergic rhinitis and at opic dermatitis. Pediatr Allergy Immunol,2006,17:422 - 427.
2Liang Y, Yeligar SM, Brown LA. Exhaled breath condensate: a promising source for biomarkers of lung disease [ J ]. Scientific- WorldJournal, 2012, [ Epub ahead of print].
3Celik D, Doruk S, Koseoglu HI, et al. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics [ J ]. Clin Chem Lab Med, 2012, [ Epub ahead of printS.
4Brindicci C, Ito K, Torre O, et al. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide produc- tion and its metabolites in healthy control subjects, healthy smok- ers, and COPD patients[J]. Chest, 2009, 135(2):353 -367.
5Liu J, Sandrini A, Thurston MC, et al. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease pa- tients[ J ]. Respiration, 2007, 74 (6) :617 - 623.
6Ahmadzai H, Huang S, Hettiarachehi R, et al. Exhaled breath condensate: a comprehensive update [ J ]. Clin Chem Lab Med, 2013, [ Epub ahead of print].
7Stefanska J, Sarniak A, Wlodarczyk A, et al. Hydrogen peroxide and nitrite reduction in exhaled breath condensate of COPD patients [J]. Pulm Pharmacol Ther, 2012, 25(5) :343 -348.
8Makris D, Paraskakis E, Korakas P, et al. Exhaled breath conden- sate 8-isoprostane, clinical parameters, radiological indices and air- way inflammation in COPD[ J]. Respiration, 2008, 75 (2) : 138 - 144.
9Montuschi P. Analysis of exhaled breath condensate in respiratory medicine:methodological aspects and potential clinical applications[J]. Ther Adv Respir Dis, 2007, 1(1) :5 -23.
10Kherad O, Kaiser L, Bridevaux PO, et al. Upper-respiratory viral infection, biomarkers, and COPD exacerbations[ J]. Chest, 2010, 138(4) :896 -904.
